ProPublica

Journalism in the Public Interest

Cancel

The Trade

The Sorry State of Bank Apologies

.

(Left: Joshua Roberts/Bloomberg via Getty Images, right: Ramin Talaie/Getty Images)

Read More »

Mary Jo White was Supposed to Turn Around the S.E.C. She Hasn’t.

The new chairwoman of the S.E.C., has made some unnecessary foes while her agency has bungled several significant regulatory rules.

Does Valeant’s Cost-Cutting Go Too Far?

Valeant ​Pharmaceuticals dragged its feet on a safety study mandated by the FDA and ran into manufacturing problems, consequences of its desire to keep costs low, according to current and former executives.

BlackRock Doesn’t Need A Scarlet Letter

The S.E.C. has a point on asset managers but it is undermining financial regulation with its public and needless antagonism of the Financial Stability Oversight Council

The Justice Department’s Foreign Aggression

The randomness and lack of transparency in its prosecution of corporations opens the Justice Department up to legitimate criticism and conspiracy theories.

Valeant’s Sugar Coating Helps its Acquisitions Go Down

Nobody really knows if Valeant Pharmaceuticals is doing anything that makes money, or is just engaged in prestidigitation that never gets anywhere.

The Buck Stops With Obama on Tepid Financial Reform

A new book by former Treasury Secretary Timothy Geithner shows the reluctance to push for serious change in the financial system after the 2008 meltdown can be traced to the very top.

Seeking Tough Justice, but Settling for Empty Promises

How the Case Against Bank of America CEO Fizzled

Years after Ken Lewis came under investigation for misleading investors, the case against him ended with a minuscule fine paid by the bank.
Jesse Eisinger

About The Trade

In this column, co-published with New York Times' DealBook, I monitor the financial markets to hold companies, executives and government officials accountable for their actions. Tips? Praise? Contact me at .(JavaScript must be enabled to view this email address)